Cann Group Limited (ASX:CAN)

Australia flag Australia · Delayed Price · Currency is AUD
0.0060
+0.0010 (20.00%)
Apr 17, 2026, 9:59 AM AEST
Market Cap8.78M -38.9%
Revenue (ttm)11.31M -27.1%
Net Income14.73M
EPS0.02
Shares Out1.60B
PE Ratio0.26
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,876,820
Average Volume3,677,265
Open0.0060
Previous Close0.0050
Day's Range0.0060 - 0.0060
52-Week Range0.0050 - 0.0230
Beta0.21
RSI41.66
Earnings DateMay 28, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia. [Read more]

Sector Healthcare
Founded 2014
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol CAN
Full Company Profile

Financial Performance

In fiscal year 2025, Cann Group's revenue was 13.25 million, a decrease of -27.81% compared to the previous year's 18.36 million. Losses were -22.35 million, -56.39% less than in 2024.

Financial Statements